Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Against Emergent BioSolutions Inc.

RADNOR, Pa., June 7, 2021 (GLOBE NEWSWIRE) – Law firm Kessler Topaz Meltzer & Check, LLP is reminding investors of Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) that the firm has filed a securities fraud class action suit before the United States District Court for the District of Maryland against Emergent on behalf of those who have purchased or acquired Emergent common stock between April 24th, 2020 and April 16th, 2021, including (the “Class Period”). This lawsuit, entitled Roth v Emergent BioSolutions Inc. et al., Case No. 1: 21-cv-01189-PX (the “Roth Action”) has been brought before the United States District Court for the District of Maryland. To view a copy of the Roth Action Complaint, please click here.

Emergent is a specialist biopharmaceutical company that develops vaccines and antibody therapeutics for infectious diseases.

The Roth lawsuit alleges that during the class action period, defendants failed to disclose: (1) Emergent’s Baltimore facility had a history of manufacturing problems that increased the likelihood of massive contamination; (2) the Baltimore facility had received a number of Food and Drug Administration (“FDA”) filings due to these contamination risks and quality control issues; (3) Emergent was forced to dump millions of doses of COVID-19 vaccines after workers at the facility deviated from manufacturing standards; and (4) as a result of the foregoing, Defendants’ public statements regarding Emergent’s ability and capacity to mass-produce multiple COVID-19 vaccines at its Baltimore facility were materially false and / or misleading and / or unfounded.

Aspiring investors can by June 18, 2021 at the latest, seek to be appointed as lead class agent through Kessler Topaz Meltzer & Check, LLP, or other legal counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in the conduct of the dispute. To be appointed as a lead plaintiff, the court must determine that the class plaintiff’s claim is typical of the claims of other class plaintiffs and that the class plaintiff is adequately representing the class action. Your ability to participate in a recovery will not be affected by whether or not you will be the lead plaintiff.

The story goes on

Kessler Topaz Meltzer & Check, LLP pursues class actions in state and federal courts across the country involving securities fraud, fiduciary violations, and other violations of state and federal laws. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform and has collected billions of dollars on behalf of institutional and private investors from the US and around the world. The firm represents investors, consumers and whistleblowers (individuals who report fraudulent practices against the government and participate in recovery of government dollars). For more information on Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

CONTACT:

Kessler Topas Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 König-von-Preußen-Strasse
Radnor, PA 19087
(844) 887-9500 (toll free)
[email protected]

Comments are closed.